Education
About Us
Working with TipRanks
Follow Us
Kainos Laboratories, Inc. (JP:4556)
:4556
RESEARCH TOOLSreports
4556 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥1,035.00 - ¥1,321.00
Previous CloseN/A
Volume2.10K
Average Volume (3M)1.09K
Market Cap
¥5.03B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.1
Beta0.21
Next Earnings
Jul 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield2.6%
Share Statistics
EPS (TTM)35.79
Shares Outstanding4,558,860
10 Day Avg. Volume1,280
30 Day Avg. Volume1,086
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4556 FAQ
What was Kainos Laboratories, Inc.’s price range in the past 12 months?
Kainos Laboratories, Inc. lowest stock price was ¥1035.00 and its highest was ¥1321.00 in the past 12 months.
What is Kainos Laboratories, Inc.’s market cap?
Kainos Laboratories, Inc.’s market cap is ¥5.03B.
When is Kainos Laboratories, Inc.’s upcoming earnings report date?
Kainos Laboratories, Inc.’s upcoming earnings report date is Jul 25, 2025 which is in 19 days.
How were Kainos Laboratories, Inc.’s earnings last quarter?
Kainos Laboratories, Inc. released its earnings results on May 09, 2025. The company reported ¥35.79 earnings per share for the quarter, beating the consensus estimate of N/A by ¥35.79.
Is Kainos Laboratories, Inc. overvalued?
According to Wall Street analysts Kainos Laboratories, Inc.’s price is currently Overvalued.
Does Kainos Laboratories, Inc. pay dividends?
Kainos Laboratories, Inc. pays a Annually dividend of ¥35 which represents an annual dividend yield of 2.6%. See more information on Kainos Laboratories, Inc. dividends here
What is Kainos Laboratories, Inc.’s EPS estimate?
Kainos Laboratories, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kainos Laboratories, Inc. have?
Kainos Laboratories, Inc. has 4,558,860 shares outstanding.
What happened to Kainos Laboratories, Inc.’s price movement after its last earnings report?
Kainos Laboratories, Inc. reported an EPS of ¥35.79 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.358%.
Which hedge fund is a major shareholder of Kainos Laboratories, Inc.?
Currently, no hedge funds are holding shares in JP:4556
Company Description
Kainos Laboratories, Inc.
Kainos Laboratories, Inc. (4556) is a pharmaceutical company that operates in the healthcare sector, specializing in the development, production, and marketing of a wide range of pharmaceutical products. The company focuses on creating innovative drugs and therapies aimed at improving patient outcomes and addressing unmet medical needs. Kainos Laboratories is committed to research and development, leveraging advanced technologies to bring effective solutions to the market.
Technical Analysis
JMS Co., Ltd.
―
Mani, Inc.
―
Seed Co., Ltd.
―
Shofu Inc.
―
Shigematsu Works Co., Ltd.
―